Sarepta Therapeutics, Inc.
Peptide oligonucleotide conjugates

Last updated:

Abstract:

Provided herein are oligonucleotides, peptides, and peptide-oligonucleotide-conjugates. Also provided herein are methods of treating a muscle disease, a viral infection, or a bacterial infection in a subject in need thereof, comprising administering to the subject oligonucleotides, peptides, and peptide-oligonucleotide-conjugates described herein.

Status:
Grant
Type:

Utility

Filling date:

28 Apr 2020

Issue date:

24 Aug 2021